SZN-16051-31986 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-12-04
Dose 1 — Pfizer-BioNTech
2021-12-26
Dose 2 — Pfizer-BioNTech
2022-06-06
Dose 3 — Pfizer-BioNTech
2022-06-29
Registered in v-safe
2022-06-29
Health check-in — day 21, dose 3, dependent
Feeling: Good

Adult check-in
2022-07-06
Health check-in — day 28, dose 3, dependent
Feeling: Good

Adult check-in
2022-07-11
Health check-in — day 35, dose 3, dependent
Feeling: Good

Adult check-in
2022-07-18
Health check-in — day 42, dose 3, dependent
Feeling: Good

Adult check-in
2022-09-05
Health check-in — 3 months, dose 3, dependent
Feeling: Good

Adult check-in
2022-12-05
Survey response — 6 months, dose 3, dependent
MedDRA: Cough, Nasopharyngitis, Oropharyngeal pain, Pain, Pyrexia — Feeling: Poor · Be unable to work or attend school

Free text: Fever, body aches, cough, cold, sore throat

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-12-04	Pfizer-BioNTech	No
2	2021-12-26	Pfizer-BioNTech	No
3	2022-06-06	Pfizer-BioNTech	No

Free text

Release 12 — 6 months, dose 3, dependent

2022-12-05

Symptoms: Fever, body aches, cough, cold, sore throat

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Pain	·	·	✓
SD	Pyrexia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release